Baillie Gifford & CO Jazz Pharmaceuticals PLC Transaction History

Baillie Gifford & CO

  • $131 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023
BUY
$133.98 - $160.47 $3,349 - $4,011
25 Added 14.88%
193 $28,000
Q2 2022

Aug 08, 2022
BUY
$141.59 - $168.66 $424 - $505
3 Added 1.82%
168 $26,000
Q4 2021

Jan 20, 2022
BUY
$119.87 - $145.67 $19,778 - $24,035
165 New
165 $21,000

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email